Table 1

Baseline features of the studied population according to the use of colchicine

Colchicine (−) (n=64)Colchicine (+) (n=192)P value
Gender, n (%)0.76
 Female41 (64.1)127 (66.1)
 Male23 (35.9)65 (33.9)
Age, mean (SD)45.4 (16.0)44.9 (15.2)0.81
Idiopathic/viral aetiology, n (%)56 (87.5)151 (78.6)0.12
Fever, n (%)19 (29.7)58 (30.2)0.94
Cardiovascular risk factors, n (%)37 (57.8)114 (59.4)0.83
Pericardial effusion, n (%)32 (50.0)82 (42.7)0.31
Pericardial disease duration, months, median (IQR)24 (10.9–51)25 (10.6–46.1)0.88
Previous pericarditis recurrences, median (IQR)3 (2.5–4.5)3 (3–5)0.51
CRP>5, n (%)41 (64.1)111 (57.8)0.38
NSAIDs, n (%)28 (43.8)100 (52.1)0.25
Corticosteroids, n (%)43 (67.2)154 (80.2)0.032
12 months-follow up64 (100)192 (100)
  • Bold type p values of data considered for multivariable analysis.

  • CRP, C reactive protein; NSAIDs, non-steroidal anti-inflammatory drugs.